ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ORGO vs VTVT // 10Y YIELD & FRED MACRO BETA

Organogenesis Holdings Inc. (Class A) (NASDAQ) VS. vTv Therapeutics Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: ORGO 5 — VTVT 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ORGO VS. VTVT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ORGO VTVT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 17.10% -35.00% +52.10 ORGO /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -23.21% -24.21% +1.00 ORGO /fcf-yield <GO>
Operating Margin 7.90% — — TIE /operating-margins <GO>
Net Profit Margin 6.60% — — TIE /net-margins <GO>
Revenue Growth (YoY) 17.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.09 0.20 +1.89 ORGO /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 ORGO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 15.6 32.8 -17.23 VTVT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $105.4M $104.3M $1.1M ORGO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ORGO REV VTVT REV ORGO GROSS % VTVT GROSS % ORGO FCF VTVT FCF
FY 2025 $564.2M $0 — — -$24.5M -$25.3M
FY 2024 $482.0M $1.0M 76.0% — $4.2M -$25.3M
FY 2023 $433.1M $0 — — $30.9M -$19.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ORGO // BETA —
VTVT // BETA —